rbd | Media Room | PressRelease.com

Press Release Distribution
Pricing
Customer Support

(800) 998-2927 Login Log In

Health

Other

Tagged rbd

POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19

Press Release Nov 30, 2022

POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19

Read More

First
Prev

1

Next
Last

Press Release Distribution

Press Release
Press Release Plus
Public Company Press Release
International Press Release

Customer Success

Customer Support

Resources

Newsroom
Blog
Email Customer Support

© PressRelease.com

Terms of Service
Privacy